In issue 16(3-4) of the *Journal of Toxicology and Environmental Health, Part B*, in the article "Pesticide Exposure and Neurodevelopmental Outcomes: Review of the Epidemiologic and Animal Studies" by Carol J. Burns, Laura J. McIntosh, Pamela J. Mink, Anne M. Jurek, and Abby A. Li, corrections to [Tables 10](#T0001){ref-type="table"}, 14, 16 and 18 were discovered by the authors post-publication. TABLE 10.Organophosphate *in vivo* mammalian studies (rows with corrections)CompoundTotal Number of Papers Evaluated^a^Exposure Period(s) for Which Literature Is Available^b^Total Number of Studies Evaluated^a^ for Each Exposure PeriodSpecies (\# of studies)Route^c^ (\# of studies)Litter of Origin Was Unit of Analysis(\# of studies)Dose/ Response within the Study^d^ (\# of studies)Number of Studies with ≥ 6 LittersBrain AChE inhibition MeasuredLowest Offspring NOEL/LOEL, First Author, Year, (Neuro Endpoints) mg/kgOffspring brain or RBC AChE inhibition NOEL or LOEL Author, Year mg/kgRegulatory Numbers (mg/kg/day)**Chlorpyrifos62Gestation only26** See references below^e^**rat (18)mouse (8)oral (9)dermal (3)s.c. (14; thirteen DMSO)131919120.1**, Abdel Rahman 2003,2004; LOEL (increase brain AChE activity)**0.1** brain LOEL, Abdel-Rahman 2003, 2004EPA RED Chronic PAD (2011): BMDL~10~ 0.03 / UF 100, FQPA 1 = 0.0003JMPR ADI: 0.01(2004); EU: ADI 0.01 (2005) UF 100  **PND direct dosing to pups38** See references below^f^**rat (34)mouse (4)oral (12)s.c. (26, twenty- one DMSO)111528180.3**, Jett 2001; LOEL (spatial learning)**0.75** brain, RBC NOEL, Zheng 2000 **Dichlorvos7Gestation only5** Dambska et al., 1979, Desi and Nagymajtenyi, 1999, Maslinska and Zalewska, 1978, Mehl et al., 1994, Zalewska et al., 1977**rat (2)rabbit (2)guinea pig (1)oral (2)not stated (3)32141.1**, Zalewska 1977; LOEL (brain AChE inhibition)**1.1** brain LOEL, Zalewska 1977EPA RED Chronic RfD (2006): NOEL 0.05 / UF 100, FQPA 1 =0.0005JMPR ADI (2010): 0.004, EU (UF 10) (tentative) ADI: 0.00008 (2006)              **Dichlorvos (cont.)** **PND direct dosing to pups (new row)2** Dambski and Maslinska, 1988, Maslinski et al., 1981**rabbit (2)oral (2)01014.0**, Desi 1999; NOEL (electro-physiology)**4.0** brain NOEL, Desi 1999 **Parathion13Gestation only3** al-Hachim and Fink, 1968 a,b,c**mouse (3)oral (1) not stated (3)0030[\>]{.ul}3**, al-Hachim and Fink, 1968 a,b,c; NOEL (behavior and electrophysiology)**Not measured**EPA RED Chronic RfD 0.006, POD not available cancellation of US registrations 2006  **PND direct dosing to pups9** Dvergsten and Meeker 1994, Levin et al. 2010, Slotkin et al. 2006a,b, 2008, 2009a,b, Stamper et al 1988, Timofeeva et al. 2008b, Veronesi and Pope, 1990**rat (10)s.c. (10; seven DMSO)110840.02**, Slotkin 2006b; NOEL (brain AChE inhibition)**0.02** brain NOEL, Slotkin 2006bJMPR ADI (2000): 0.004, EU (2001) ADI 0.0006

In most cases, the errors were related to incorrect selection of Endnote references and slight miscounting of studies with different characteristics. In two cases, the NOEL/LOELs were corrected to higher dose levels, and, hence, higher than the reference doses listed in the "Regulatory Number" column. For 3 organophosphates from [Table 10](#T0001){ref-type="table"}, the row(s) needing corrections are presented in tabular form for clarity. None of these changes impact the scientific conclusions of this review paper.

[TABLE 10](#T0001){ref-type="table"}

**References in footnotes "e" and "f"** (We include all the references for each author citation for which there was at least one missing or incorrect reference):

*^e^Chlorpyrifos gestation-only references:* Aldridge et al., 2003, 2004, 2005b, Slotkin and Seidler, 2007a.

*^f^Chlorpyrifos PND direct dosing references:* Ricceri et al., 2003, 2006, Slotkin et al., 2001, 2002, 2004, 2006a, [@CIT0002], Venerosi et al., 2006, 2008, Tang et al. 1999.

**Diazinon "gestation only"** unit of analysis was litter of origin: 0 studies

**Trichlorfon "gestation only"** unit of analysis was litter of origin: 1 study

Additional corrections made in the abbreviated [Table 10](#T0001){ref-type="table"} below.

TABLE 14

 {#S0002}

Chlordecone {#S2001}
-----------

*PND direct dosing:* offspring NOEL for Gray et al. 1982 is 0.25 mg/hamster pup (PND 4) instead of 0.25 mg/kg body weight. Since hamster pup weights were not provided to convert to mg/kg, the lowest NOEL is changed to 22 mg/kg based on Tilson et al. 1982 (dose level of 0.2 mg/ rat pup and PND 4 rat pup weights of 9-10 g from [Table 1](#T0001){ref-type="table"} of that paper).

*Gestation and PND:* 3 (not 2) studies had dose response data; lowest LOEL was 0.1 mg/kg body weight based on EPA IRIS (2009) conversion from 1 ppm in diet (Squibb 1982; U.S. EPA, 2009 <http://www.epa.gov/iris/toxreviews/1017tr.pdf>)

*PND through dams [\>]{.ul}6 litters/dose group:* 0 studies

Endosulfan {#S2002}
----------

*PND direct dosing [\>]{.ul}6 litters/dose group:* 1 study

*Gestation and PND [\>]{.ul}6 litters/dose group:* 0 studies

Heptachlor {#S2003}
----------

*Gestation only [\>]{.ul}6 litters/dose group:* 1 study

TABLE 16

Allethrin: {#S2004}
----------

*PND direct dosing [\>]{.ul} 6 litters/dose group:* 0 studies

TABLE 18

**Atrazine**: Exposure period is gestation with or without PND exposure because Belloni et al., 2011 included both gestation and PND exposure.

**Paclobutrazol**: Exposure period is GD only; litter was unit of analysis for 0 studies

**Piperonyl butoxide**: litter was unit of analysis for 1 study
